MedTrace Logo

Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation

NCT06719232 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-12-12

No results posted yet for this study

Summary

This study aims to evaluate a catheter-free method for delivering medications directly into the bladder, known as intravesical instillation, which is commonly used to treat conditions such as interstitial cystitis/bladder pain syndrome (IC/BPS), recurrent urinary tract infections, bladder cancer, and post-chemotherapy or post-radiation cystitis.

The study investigates whether this method, which eliminates the need for catheterization, reduces discomfort and complications while maintaining treatment effectiveness. By collecting data on patient experiences and outcomes, the study seeks to determine if this approach provides a safer and more comfortable alternative to traditional catheter-based treatments.

Conditions

  • Interstitial Cystitis
  • Recurrent Cystitis
  • Haemorrhagic Cystitis
  • Bladder Cancer
  • Bladder Disease
  • Intravesical Instillation
  • Bladder Pain Syndrome
  • Recurrent Urinary Tract Infections

Interventions

DEVICE

Catheter-Free Intravesical Instillation with a special syringe adapter

The intervention involves catheter-free intravesical instillation using a specialized urological adapter. This device is attached to a syringe and inserted approximately 6-8 mm into the urethral opening, allowing the instillation solution to reach the bladder without the need for catheterization.

Sponsors & Collaborators

  • Jahn Ferenc South Pest Teaching Hospital

    lead OTHER_GOV

Principal Investigators

  • Peter Tenke, Professor of Urology · South Pest Teaching Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06719232 on ClinicalTrials.gov